Metix Ltd2020-05-04T11:08:29+00:00
VTime Ltd

Metix has developed a suite of portable, multi-parameter, non-invasive, hand-held emergency vital signs monitors. “Where Emergency Medicine Begins.”

Metix is a new generation healthcare company that provides patient surveillance and monitoring services. Founded in November 2013, the Company has developed a suite of portable, multi-parameter, non-invasive, hand-held emergency vital signs monitors.

Monitoring vital signs including blood pressure, pulse rate, respiration rate, heart rate, temperature and oxygen saturation, is a crucial aspect of patient care. Vital signs indicate a patient’s clinical condition and are necessary to calculate early warning scores which are used to determine the monitoring, escalation and interventions that are subsequently required.

Metix leverages extensive expertise in bioengineering, data analytics, medically qualified firmware, regulatory processes and mobile and cloud software, to create technology that supports decision making paradigms to achieve better health and economic outcomes.


COVID-19 Response:

During the Coronavirus pandemic, Metix advises that they have been liaising with the Spanish, UK and US Governments regarding COREMED X as a potential tool for monitoring Covid-19 isolated patients and where there is limited monitoring capacity, such as makeshift hospitals and in the community.

  • Sector: HealthTech

  • Region: UK: Scotland

  • Stage: Growth – pre-revenue

  • Eligible Tax: EIS

  • Funding: £1,000,000

  • Status: LIVE

76% funded 76%

Log in
  to join our private investor network.

Need to know more?

For further information please do not hesitate to get in touch.

Contact Us

This website uses cookies and third party services. Deepbridge Syndicate is designed for non-advised, appropriate investors looking to invest into single EIS-eligible companies, with a minimum investment of £10,000. For persons not meeting this criteria please visit WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to sell shares; the loss of the value of investment; dilution of shareholding and investing in single company investment should be done only as part of a diversified portfolio. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme. Please read full Risk Warning. By continuing to view this website you are confirming you have read the above notification and risk warning.